Calcium, bioenergetics, and Parkinson's disease

E Zampese, DJ Surmeier - Cells, 2020 - mdpi.com
Degeneration of substantia nigra (SN) dopaminergic (DAergic) neurons is responsible for
the core motor deficits of Parkinson's disease (PD). These neurons are autonomous …

Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies

P Chmielarz, M Saarma - Pharmacological Reports, 2020 - Springer
Background Neurotrophic factors are endogenous proteins promoting the survival of
different neural cells. Therefore, they elicited great interest as a possible treatment for …

Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson's disease models

B Song, Y Cha, S Ko, J Jeon, N Lee… - The Journal of …, 2020 - Am Soc Clin Investig
Parkinson's disease (PD) is a neurodegenerative disorder associated with loss of striatal
dopamine, secondary to degeneration of midbrain dopamine (mDA) neurons in the …

A dual role for α-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo

M Somayaji, S Cataldi, SJ Choi… - Proceedings of the …, 2020 - National Acad Sciences
α-Synuclein is expressed at high levels at presynaptic terminals, but defining its role in the
regulation of neurotransmission under physiologically relevant conditions has proven …

Calcium-handling defects and neurodegenerative disease

S Schrank, N Barrington… - Cold Spring Harbor …, 2020 - cshperspectives.cshlp.org
Calcium signaling is critical to neuronal function and regulates highly diverse processes
such as gene transcription, energy production, protein handling, and synaptic structure and …

Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalk

YN Paudel, E Angelopoulou, C Piperi, MF Shaikh… - Pharmacological …, 2020 - Elsevier
Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by the
progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and …

Selective neuronal vulnerability in Parkinson's disease

P Gonzalez-Rodriguez, E Zampese… - Progress in brain …, 2020 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disease, disabling
millions worldwide. Despite the imperative PD poses, at present, there is no cure or means …

Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications

L Rani, AC Mondal - Mitochondrion, 2020 - Elsevier
Mitochondria are very dynamic organelle which plays a multifactorial role for a broad range
of physiological processes inside the cell to maintain neural circuit integrity. They are …

Mitochondrial dysfunction combined with high calcium load leads to impaired antioxidant defense underlying the selective loss of nigral dopaminergic neurons

KM Ricke, T Paß, S Kimoloi, K Fährmann… - Journal of …, 2020 - Soc Neuroscience
Mitochondrial dysfunction is critically involved in Parkinson's disease, characterized by loss
of dopaminergic neurons (DaNs) in the substantia nigra (SNc), whereas DaNs in the …

Mechanism of manganese dysregulation of dopamine neuronal activity

M Lin, LM Colon-Perez, DO Sambo… - Journal of …, 2020 - Soc Neuroscience
Manganese exposure produces Parkinson's-like neurologic symptoms, suggesting a
selective dysregulation of dopamine transmission. It is unknown, however, how manganese …